AI for diagnosing and treating brain diseases in older adults
Part of Brain & nervous system, Mental health clinical trials.
This study uses artificial intelligence to help diagnose and treat brain diseases that affect older adults, such as Parkinson's and Alzheimer's. Researchers will compare AI methods with standard care to see if they can improve diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Parkinson's disease, Alzheimer's disease, or another neurodegenerative disease.
- Or you are a healthy older adult (60+) or a healthy younger adult (under 60) for comparison.
- You do not have other brain conditions like stroke, brain injury, infection, or tumor.
- You do not have severe mental illness that prevents cooperation.
- If you have Parkinson's or Alzheimer's, you should not have significant memory problems (MMSE score 24 or above).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced computer technology to analyze brain images and other data to help diagnose Alzheimer's disease and related memory problems. By participating, you may contribute to improving early detection and understanding of these conditions.
This study uses artificial intelligence to analyze videos of standard motor tests (MDS-UPDRS Part III) for people with Parkinson's disease. It aims to see if AI can reliably assess your symptoms, which could lead to easier, more accessible monitoring in the future.
This study looks for “autoimmune-like” (immune-system) features in brain-related diseases such as Parkinson’s and Alzheimer’s, using genetic testing and other assessments. Results may help researchers understand what drives these conditions and who might be more likely to have immune-related changes.
This study uses artificial intelligence to look for early signs of Alzheimer's disease in people who have memory concerns but normal test scores. It may help identify who is at risk earlier.
This study is looking for proteins in blood and other body fluids that could help detect brain diseases like Parkinson's, Alzheimer's, and ALS early. It aims to improve diagnosis and future treatments.
This trial uses new technology (like sensors or apps) to help diagnose and monitor Parkinson's disease early. Researchers want to see if a simple, widespread healthcare service model can improve care. Both people with Parkinson's and healthy volunteers are needed.
Hear when a new Nervous System Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.